Greenhouse Gas Emissions from Respiratory Treatments : Results from the SABA CARBON International Study
| dc.contributor.author | Alzaabi, Ashraf | |
| dc.contributor.author | Bell, John P. | |
| dc.contributor.author | Montero-Arias, Felicia | |
| dc.contributor.author | Price, David B. | |
| dc.contributor.author | Jackson, David J. | |
| dc.contributor.author | Wang, Hao-Chien | |
| dc.contributor.author | Budgen, Nigel | |
| dc.contributor.author | Farouk, Hisham | |
| dc.contributor.author | Maslova, Ekaterina | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2023-09-11T14:27:00Z | |
| dc.date.available | 2023-09-11T14:27:00Z | |
| dc.date.issued | 2023-11 | |
| dc.description | Acknowledgements Medical Writing, Editorial, and Other Assistance Medical writing and editorial support were provided by Tejaswini Subbannayya, PhD, of Cactus Life Sciences (part of Cactus Communications, Mumbai, India), in accordance with Good Publication Practice (GPP3) guidelines (http://www.ismpp.org/gpp3). This support was fully funded by AstraZeneca. Funding AstraZeneca funded the study; was involved in the study design, protocol development, study conduct and statistical analysis; and was given the opportunity to review the manuscript before submission. AstraZeneca also funded medical writing support and the development of the graphical abstract. AstraZeneca funded the journal’s Rapid Service and Open Access fees. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 21 | |
| dc.format.extent | 1313644 | |
| dc.identifier | 281209411 | |
| dc.identifier | 6b352fac-3bed-44e8-add6-ea84a81c265c | |
| dc.identifier | 37684493 | |
| dc.identifier | 85170205350 | |
| dc.identifier.citation | Alzaabi, A, Bell, J P, Montero-Arias, F, Price, D B, Jackson, D J, Wang, H-C, Budgen, N, Farouk, H & Maslova, E 2023, 'Greenhouse Gas Emissions from Respiratory Treatments : Results from the SABA CARBON International Study', Advances in Therapy, vol. 40, no. 11, pp. 4836-4856. https://doi.org/10.1007/s12325-023-02663-2 | en |
| dc.identifier.doi | 10.1007/s12325-023-02663-2 | |
| dc.identifier.iss | 11 | en |
| dc.identifier.issn | 1865-8652 | |
| dc.identifier.other | RIS: urn:128B249197A6C73799F8A6AE185A9678 | |
| dc.identifier.other | RIS: Alzaabi2023 | |
| dc.identifier.uri | https://hdl.handle.net/2164/21639 | |
| dc.identifier.vol | 40 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Advances in Therapy | en |
| dc.subject | Asthma | en |
| dc.subject | Asthma control | en |
| dc.subject | carbon footprint | en |
| dc.subject | Environmental monitoring | en |
| dc.subject | Greenhouse gas emissions | en |
| dc.subject | Inhalers | en |
| dc.subject | Inhaler therapies | en |
| dc.subject | SABA | en |
| dc.subject | Short-acting β2-agonist | en |
| dc.subject | R Medicine | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | R | en |
| dc.title | Greenhouse Gas Emissions from Respiratory Treatments : Results from the SABA CARBON International Study | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Alzaabi_etal_AT_Greenhouse_Gas_Emissions_VoR.pdf
- Size:
- 1.25 MB
- Format:
- Adobe Portable Document Format
